Insulin treatment persistence varies among payers March 25, 2017By Tracey WalkerA study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States. How to target high-risk populations with behavioral health March 23, 2017By Ron Geraty MDHere are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions. Start MACRA reporting with a HIPAA risk assessment, or don’t start at all March 23, 2017By Art GrossHere are five key security risk assessment elements to identify and remediate. Opinion: More industry-stakeholders play blame game for high drug costs March 23, 2017By Devon Herrick PhDOur policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs. Inaccurate provider directories create barriers to careHere are four ways that health plans can improve their internal processes for collecting provider data. Five pharmacy regulations health execs must keep on their radars in 2017 March 19, 2017By Kenneth MaxikHere are five critical regulations that executives can begin to prepare for today. What more transparency at the FDA means for health executives March 19, 2017By Tracey WalkerResearchers create a set of recommendations for transparency at the agency in five principal areas. Strategic planning amidst uncertainty: 10 considerations for health execsHealthcare leaders are concerned about developing reliable strategies for the future. Is effective strategic and financial planning even possible with so many variables up in the air? Four ways Trump will shift digital healthcare
March 16, 2017With ACA repeal and replace on the horizon, digital healthcare solutions will surely be affected.
GOP ACA replacement plan: 4 things health execs should know March 16, 2017By Karen AppoldWhat should managed care executives know about the GOP ACA replacement plan? Find out.